Friday, September 12, 2014

La Jolla's Orexigen Gets FDA Approval for Weight-Loss Pill Contrave

Results from another trial with patients suffering from type 2 diabetes showed that they had an average weight loss of 2 percent with Contrave as compared to placeboes. In this trial, 36 percent of patients who used Contrave lost at least 5 percent of





via Get Fit Bookmark http://ift.tt/1AFv07T




via Tumblr http://ift.tt/1tGgMRG

No comments:

Post a Comment